Recognizing the critical roles of proteins such as GAP43, PSD95, and synaptophysin in synaptic plasticity and recovery following stroke, we aimed to assess whether rNPFF treatment could increase the expression of these markers, thereby supporting synaptic integrity under ischemic conditions. The gene discussed is GAP43; the disease is stroke disorder.